[1] Biswas SK, Sarai M, Hishida H, et al. 123I-BMIPP fatty acid analogue imaging is a novel diagnostic and prognostic approach following acute myocardial infarction. Singapore Med J, 2009, 50(10): 943-948.
[2] Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol, 2011, 18(1): 135-143.  doi: 10.1007/s12350-010-9305-4
[3] Wu JC, Bengel FM, Gambhir SS. Cardiovascular molecular imaging. Radiology, 2007, 244(2): 337-355.
[4] Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis, 1981, 23(5): 321-336.
[5] Schwaiger M, Neese RA, Araujo L, et al. Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol, 1989, 13(3): 745-754.  doi: 10.1016/0735-1097(89)90621-9
[6] Bergmann SR, Lerch RA, Fox KA, et al. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med, 1982, 73(4): 573-581.  doi: 10.1016/0002-9343(82)90338-2
[7] Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol, 1985, 6(2): 336-347.  doi: 10.1016/S0735-1097(85)80169-8
[8] Dilsizian V, Bateman TM, Bergmann SR, et al. Metabolic imaging with beta-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation, 2005, 112(14): 2169-2174.  doi: 10.1161/CIRCULATIONAHA.104.530428
[9]

Tamaki N, Morita K, Kawai Y. The Japanese experience with metabolic imaging in the clinical setting. J Nucl Cardiol. 2007, 14Suppl3: S145-152.
[10] Kawai Y, Tsukamoto E, Nozaki Y, et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol, 2001, 38(7): 1888-1894.  doi: 10.1016/S0735-1097(01)01634-5
[11] Watanabe K, Takahashi T, Miyajima S, et al. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina. J Nucl Med, 2002, 43(11): 1476-1481.
[12] Inaba Y, Bergmann SR. Diagnostic accuracy of beta-methyl-para-[123I]-iodophenyl-pentadecanoic acid(BMIPP) imaging: a metaanaly-sis. J Nucl Cardiol, 2008, 15(3): 345-352.  doi: 10.1016/j.nuclcard.2008.02.019
[13] Yamabe H, Fujiwara S, Rin K, et al. Resting 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med, 2000, 14(3): 187-192.
[14] Kontos MC, Dilsizian V, Weiland F, et al. Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes. J Am Coll Cardiol, 2010, 56(4): 290-299.  doi: 10.1016/j.jacc.2010.03.045
[15] Hambÿe AS, Vervaet A, Dobbeleir A, et al. Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarction. Eur J Nucl Med, 2000, 27(10): 1494-1500.  doi: 10.1007/s002590000332
[16] Nakata T, Hashimoto A, Eguchi M. Cardiac BMIPP imaging in acute myocardial infarction. Int J Card Imaging, 1999, 15(1): 21-26.
[17] Fukuchi K, Hasegawa S, Ito Y, et al. Detection of coronary artery disease by iodine-123-labeled iodophenyl-9-methyl pentadecanoic acid SPECT: comparison with thallium-201 and iodine-123 BMIPP SPECT. Ann Nucl Med, 2000, 14(1): 11-16.
[18] Fukushima Y, Toba M, Ishihara K, et al. Usefulness of 201TlCl/123I-BMIPP dual-myocardial SPECT for patients with non-ST segment elevation myocardial infarction. Ann Nucl Med, 2008, 22(5): 363-369.
[19] Nakata T, Kobayashi T, Tamaki N, et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl Med Commun, 2000, 21(10): 897-906.
[20] Ito T, Tanouchi J, Kato J, et al. Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images. Eur J Nucl Med, 1996, 23(8): 917-923.  doi: 10.1007/BF01084365
[21] Hambye AS, Vervaet A, Dobbeleir A. Quantification of 99Tcm-sestamibi and 123I-BMIPP for predicting functional outcome in chronically dysfunctional myocardium. Nucl Med Commun, 1999, 20(8): 737-745.  doi: 10.1097/00006231-199908000-00008
[22] Geeter FD, Franken PR, Defrise M, et al. Optimal collimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med, 1996, 23(7): 768-774.
[23] Mochizuki T, Murase K, Higashino H, et al. Ischemic "memory image" in acute myocardial infarction of 123I-BMIPP after reperfusion therapy: a comparison with 99mTc-pyrophosphate and 201Tl dual-isotope SPECT. Ann Nucl Med, 2002, 16(8): 563-568.  doi: 10.1007/BF02988634
[24] Amano Y, Kumita S, Takayama M, et al. Comparison of contrast-enhanced MRI with Iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy. AJR Am J Roentgenol, 2005, 185(2): 312-318.  doi: 10.2214/ajr.185.2.01850312
[25] Narita M, Kurihara T. Is I-123-beta-methyl-p-iodophenylmethyl pentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy. Int J Cardiovasc Imaging, 2003, 19(6): 499-510.  doi: 10.1023/B:CAIM.0000004262.48898.5d
[26] Narita M, Kurihara T, Sindoh T, et al. Successive myocardial fatty acid metabolic imaging in patient with dilated cardiomyopathy: usefulness as a prognostic indicator. Kaku Igaku, 2000, 37(4): 303-310.
[27] Inoue A, Fujimoto S, Yamashina S, et al. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy. Ann Nucl Med, 2007, 21(7): 399-404.  doi: 10.1007/s12149-007-0045-8
[28] Nakata T, Kobayashi T, Tamaki N, et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl Med Commun, 2000, 21(10): 897-907.  doi: 10.1097/00006231-200010000-00003
[29] Matsuki T, Tamaki N, Nakata T, et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging, 2004, 31(12): 1585-1591.  doi: 10.1007/s00259-004-1551-8
[30] Inaba Y, Bergmann SR. Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systemic review. J Nucl Cardiol, 2010, 17(1): 61-70.  doi: 10.1007/s12350-009-9157-y
[31] Nishimura M, Hashimoto T, Kobayashi H, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int, 2004, 66(2): 811-829.  doi: 10.1111/j.1523-1755.2004.00808.x
[32] Nishimura M, Hashimoto T, Kobayashi H, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int, 2004, 66(2): 811-829. Nishimura M, Tsukamoto K, Hasebe N, et al. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol, 2008, 51(2): 139-145.  doi: 10.1111/j.1523-1755.2004.00808.x
[33] Nishimura M, Tokoro T, Nishida M, et al. Prediction of cardiac death after coronary revascularization by myocardial fatty acid imaging in hemodialysis patients. Kidney Int, 2008, 74(4): 513-520.  doi: 10.1038/ki.2008.211